Quarterly report · Q2
7634.TEDINET S100S91Y
Period2023-04-01 → 2023-09-30
Filed2023-11-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 47
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥7.0bn | 2023-04-01 → 2023-09-30 | Cons. | Net sales |
| Revenue | ¥13.8bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥6.5bn | 2022-04-01 → 2022-09-30 | Cons. | Net sales |
| Operating income | ¥879m | 2023-04-01 → 2023-09-30 | Cons. | Operating income |
| Operating income | ¥806m | 2022-04-01 → 2022-09-30 | Cons. | Operating income |
| Ordinary income | ¥908m | 2023-04-01 → 2023-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥1.8bn | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥828m | 2022-04-01 → 2022-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥914m | 2023-04-01 → 2023-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥828m | 2022-04-01 → 2022-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥621m | 2023-04-01 → 2023-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.3bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥560m | 2022-04-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥623m | 2023-04-01 → 2023-09-30 | Cons. | Profit loss |
| Net income | ¥564m | 2022-04-01 → 2022-09-30 | Cons. | Profit loss |
| Total assets | ¥21.7bn | at 2023-09-30 | Cons. | Assets |
| Total assets | ¥21.2bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥20.2bn | at 2022-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥5.3bn | at 2023-09-30 | Cons. | Liabilities |
| Total liabilities | ¥5.7bn | at 2023-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥16.4bn | at 2023-09-30 | Cons. | Net assets |
| Net assets / equity | ¥15.6bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥15.0bn | at 2022-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥8.9bn | at 2023-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥9.0bn | at 2023-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥8.9bn | at 2023-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥8.9bn | at 2023-09-30 | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥9.0bn | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥8.8bn | at 2022-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥8.7bn | at 2022-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥967m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥2.3bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥816m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥601m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥1.1bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥230m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥454m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥958m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥483m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥199.16 | 2023-04-01 → 2023-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥110.56 | 2023-07-01 → 2023-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥402.98 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥180.02 | 2022-04-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥105.27 | 2022-07-01 → 2022-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 74.5% | at 2023-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 72.3% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 73.0% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 54
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2023-04-01 → 2023-09-30 | ¥562m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2023-04-01 → 2023-09-30 | ¥562m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2023-04-01 → 2023-09-30 | ¥79m |
| jpcrp040300-q2r_E03330-000Care Welfare Relatedreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥606m |
| jpcrp040300-q2r_E03330-000Care Welfare Relatedreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥606m |
| jpcrp040300-q2r_E03330-000Care Welfare Relatedreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥21m |
| jpcrp040300-q2r_E03330-000Home Medical Treatment Relatedreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥3.1bn |
| jpcrp040300-q2r_E03330-000Home Medical Treatment Relatedreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥3.1bn |
| jpcrp040300-q2r_E03330-000Home Medical Treatment Relatedreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥380m |
| jpcrp040300-q2r_E03330-000Medical Gas Equipment Installation Relatedreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥678m |
| jpcrp040300-q2r_E03330-000Medical Gas Equipment Installation Relatedreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥658m |
| jpcrp040300-q2r_E03330-000Medical Gas Equipment Installation Relatedreportable segment | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥19m |
| jpcrp040300-q2r_E03330-000Medical Gas Equipment Installation Relatedreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥122m |
| jpcrp040300-q2r_E03330-000Medical Gas Relatedreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥1.9bn |
| jpcrp040300-q2r_E03330-000Medical Gas Relatedreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥1.9bn |
| jpcrp040300-q2r_E03330-000Medical Gas Relatedreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥264m |
| jpcrp040300-q2r_E03330-000Nursing Homereportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥174m |
| jpcrp040300-q2r_E03330-000Nursing Homereportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥174m |
| jpcrp040300-q2r_E03330-000Nursing Homereportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥13m |
| —segment total | revenue | 2023-04-01 → 2023-09-30 | ¥6.4bn |
| —segment total | revenue external | 2023-04-01 → 2023-09-30 | ¥6.4bn |
| —segment total | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥19m |
| —segment total | segment profit | 2023-04-01 → 2023-09-30 | ¥800m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-04-01 → 2023-09-30 | ¥7.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-04-01 → 2023-09-30 | ¥7.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥19m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-04-01 → 2023-09-30 | ¥879m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-04-01 → 2022-09-30 | ¥617m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-04-01 → 2022-09-30 | ¥617m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-04-01 → 2022-09-30 | ¥84m |
| jpcrp040300-q2r_E03330-000Care Welfare Relatedreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥448m |
| jpcrp040300-q2r_E03330-000Care Welfare Relatedreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥448m |
| jpcrp040300-q2r_E03330-000Care Welfare Relatedreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥4m |
| jpcrp040300-q2r_E03330-000Home Medical Treatment Relatedreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥2.9bn |
| jpcrp040300-q2r_E03330-000Home Medical Treatment Relatedreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥2.9bn |
| jpcrp040300-q2r_E03330-000Home Medical Treatment Relatedreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥402m |
| jpcrp040300-q2r_E03330-000Medical Gas Equipment Installation Relatedreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥588m |
| jpcrp040300-q2r_E03330-000Medical Gas Equipment Installation Relatedreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥545m |
| jpcrp040300-q2r_E03330-000Medical Gas Equipment Installation Relatedreportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥43m |
| jpcrp040300-q2r_E03330-000Medical Gas Equipment Installation Relatedreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥103m |
| jpcrp040300-q2r_E03330-000Medical Gas Relatedreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥1.8bn |
| jpcrp040300-q2r_E03330-000Medical Gas Relatedreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥1.8bn |
| jpcrp040300-q2r_E03330-000Medical Gas Relatedreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥193m |
| jpcrp040300-q2r_E03330-000Nursing Homereportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥178m |
| jpcrp040300-q2r_E03330-000Nursing Homereportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥178m |
| jpcrp040300-q2r_E03330-000Nursing Homereportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥19m |
| —segment total | revenue | 2022-04-01 → 2022-09-30 | ¥5.9bn |
| —segment total | revenue external | 2022-04-01 → 2022-09-30 | ¥5.9bn |
| —segment total | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥43m |
| —segment total | segment profit | 2022-04-01 → 2022-09-30 | ¥721m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-09-30 | ¥6.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-09-30 | ¥6.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥43m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2022-09-30 | ¥806m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 503
| Item | Context | Value | Unit |
|---|---|---|---|
| Loss gain on sales and retirement of property plant and equipment ope cf | Prior1YTDDuration | － | JPY |
| Loss gain on sales and retirement of property plant and equipment ope cf | CurrentYTDDuration | -3791000 | JPY |
| Decrease increase in notes and accounts receivable trade ope cf | Prior1YTDDuration | 210612000 | JPY |
| Decrease increase in notes and accounts receivable trade ope cf | CurrentYTDDuration | 236728000 | JPY |
| Decrease increase in inventories ope cf | Prior1YTDDuration | -35575000 | JPY |
| Decrease increase in inventories ope cf | CurrentYTDDuration | -23383000 | JPY |
| Increase decrease in notes and accounts payable trade ope cf | Prior1YTDDuration | -344532000 | JPY |
| Increase decrease in notes and accounts payable trade ope cf | CurrentYTDDuration | -203631000 | JPY |
| Other net ope cf | Prior1YTDDuration | -44869000 | JPY |
| Other net ope cf | CurrentYTDDuration | -3560000 | JPY |
| Subtotal ope cf | Prior1YTDDuration | 1079832000 | JPY |
| Subtotal ope cf | CurrentYTDDuration | 1248006000 | JPY |
| Interest and dividends income received ope cf inv cf | Prior1YTDDuration | 15093000 | JPY |
| Interest and dividends income received ope cf inv cf | CurrentYTDDuration | 20570000 | JPY |
| Interest expenses paid ope cf fin cf | Prior1YTDDuration | -3342000 | JPY |
| Interest expenses paid ope cf fin cf | CurrentYTDDuration | -2649000 | JPY |
| Income taxes paid ope cf | Prior1YTDDuration | -275522000 | JPY |
| Income taxes paid ope cf | CurrentYTDDuration | -298769000 | JPY |
| Net cash provided by used in operating activities | Prior1YTDDuration | 816061000 | JPY |
| Net cash provided by used in operating activities | CurrentYTDDuration | 967157000 | JPY |
| Payments into time deposits inv cf | Prior1YTDDuration | -60000000 | JPY |
| Payments into time deposits inv cf | CurrentYTDDuration | － | JPY |
| Proceeds from withdrawal of time deposits inv cf | Prior1YTDDuration | 60000000 | JPY |
| Proceeds from withdrawal of time deposits inv cf | CurrentYTDDuration | 40000000 | JPY |
| Purchase of property plant and equipment inv cf | Prior1YTDDuration | -287332000 | JPY |
| Purchase of property plant and equipment inv cf | CurrentYTDDuration | -122563000 | JPY |
| Proceeds from sales of property plant and equipment inv cf | Prior1YTDDuration | － | JPY |
| Proceeds from sales of property plant and equipment inv cf | CurrentYTDDuration | 9089000 | JPY |
| Purchase of intangible assets inv cf | Prior1YTDDuration | -19240000 | JPY |
| Purchase of intangible assets inv cf | CurrentYTDDuration | -1300000 | JPY |
| Purchase of investment securities inv cf | Prior1YTDDuration | -17119000 | JPY |
| Purchase of investment securities inv cf | CurrentYTDDuration | -520984000 | JPY |
| Proceeds from redemption of investment securities inv cf | Prior1YTDDuration | 100026000 | JPY |
| Proceeds from redemption of investment securities inv cf | CurrentYTDDuration | 250000 | JPY |
| Collection of long term loans receivable inv cf | Prior1YTDDuration | 618000 | JPY |
| Collection of long term loans receivable inv cf | CurrentYTDDuration | 620000 | JPY |
| Other payments inv cf | Prior1YTDDuration | -11043000 | JPY |
| Other payments inv cf | CurrentYTDDuration | -6472000 | JPY |
| Other proceeds inv cf | Prior1YTDDuration | 4548000 | JPY |
| Other proceeds inv cf | CurrentYTDDuration | 442000 | JPY |
| Net cash provided by used in investment activities | Prior1YTDDuration | -229541000 | JPY |
| Net cash provided by used in investment activities | CurrentYTDDuration | -600919000 | JPY |
| Payments for acquisition of subsidiaries not resulting in change in scope of consolidation fin cf | Prior1YTDDuration | － | JPY |
| Payments for acquisition of subsidiaries not resulting in change in scope of consolidation fin cf | CurrentYTDDuration | -10000000 | JPY |
| Repayments of lease obligations fin cf | Prior1YTDDuration | -389677000 | JPY |
| Repayments of lease obligations fin cf | CurrentYTDDuration | -351997000 | JPY |
| Repayment of long term loans payable fin cf | Prior1YTDDuration | － | JPY |
| Repayment of long term loans payable fin cf | CurrentYTDDuration | -180000 | JPY |
| Cash dividends paid fin cf | Prior1YTDDuration | -93336000 | JPY |
| Cash dividends paid fin cf | CurrentYTDDuration | -92302000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |